Svetlana Ni Makhni
CIK: 0002129497
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PRME
Prime Medicine, Inc.
Officer
Discretionary Trading P&L
Holdings
About Makhni Svetlana Ni
Makhni Svetlana Ni (SEC CIK 0002129497) files insider reports with the SEC as Chief Financial Officer of Prime Medicine, Inc. (PRME).
Signal8 holds 2 ownership filings by Makhni Svetlana Ni (1 Form 3, 1 Form 4), filed on Apr 17, 2026. Those filings report 1 transaction, the latest on Apr 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Makhni Svetlana Ni's filings is in CAMBRIDGE, MA.
Recent filings by Makhni Svetlana Ni
- Apr 16, 2026: Grant or award of PRME derivative securities (Form 4, code A).
Other insiders filing for Prime Medicine, Inc. (PRME)
- Schenkein David P, Director
- Marrazzo Jeffrey D, Director
- NELSEN ROBERT, Director
- Kelly Michael Aaron, Director
- Foster-Cheek Kaye I, Director
- Chung Wendy, Director